Cognitive & Neuropeptides
Nootropic and neuroprotective research peptides from the Russian academic tradition. Selank (TP-7) as a Tuftsin analogue for studies on anxiolysis and immune modulation, Semax as an ACTH fragment 4-10 for research on BDNF/NGF expression and cognitive resilience, plus the popular Semax-Selank combination. All three have been studied since the 1990s at the Institute of Molecular Genetics (RAS) in Moscow and are clinically approved in Russia, while remaining research compounds in the West. Every batch ships with a batch-specific HPLC CoA from Janoshik Analytical.
All products
Related research
July 20, 2026
Exotic Nootropic Peptides vs Semax and Selank: What the Evidence Actually Shows
Dihexa, Pinealon and Cerebrolysin get talked up as next-generation nootropics. A hard look at the evidence, including a major retraction, versus the better-documented research base for Semax and Selank.
Read more →
July 20, 2026
Intranasal Peptides: Delivery, Bioavailability and Which Ones Are Studied This Way
How the intranasal route works for peptides: the olfactory and trigeminal nose-to-brain pathways, why peptides struggle to reach the brain, and which research peptides (Semax, Selank, DSIP) are studied intranasally.
Read more →
July 20, 2026
Peptides in Sleep Research: DSIP, Epitalon and the GH-Sleep Axis
Three different ways peptides intersect with sleep research: DSIP's weak delta-sleep hypothesis, Epitalon's pineal-melatonin circadian angle, and the growth-hormone-slow-wave-sleep axis where GHRH analogues sit.
Read more →
